한글목차

디지털 병리학 시장은 2025년에 11억 1,280만 달러로 평가되었고, 2032년까지 24억 9,100만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 12.2%를 나타낼 것으로 예측됩니다.

디지털 병리학은 전체 슬라이드 이미지 스캐너를 사용하여 유리 슬라이드를 디지털화한 다음 일반적으로 컴퓨터 모니터나 모바일 장치에서 이미지 뷰어를 사용하여 디지털 이미지를 분석하는 프로세스입니다. 디지털 병리학은 더 나은 시인성을 제공하고 분석의 정확성을 향상시킵니다. 이로 인해 진단 오류 발생률이 저하됩니다. 또한 이러한 도구는 서비스 제공업체에게 과거 사례를 즉시 참조하고 비교하는 기능을 제공합니다. 이러한 고급 시스템은 장기 예측 분석에 활용하기 위한 데이터를 저장합니다. 표본에는 바코드가 부착되어 오식별 위험을 줄입니다. 또한 슬라이드 손상으로 인한 데이터 유출의 우려도 사라집니다. 현대에서 디지털 병리학은 질병 진단 정확도 향상, 회복 시간 단축, 병리 전문의의 생산성 향상 등 많은 이점을 제공합니다. 이러한 이점은 의료기관에서 질병 진단에 디지털 병리학 플랫폼을 채택하는 경향을 강화하고 있으며, 주요 시장 기업이 제품 출시 프로세스에 진입하고 있습니다.

시장 역학

예측 기간 동안 혁신적인 디지털 병리학 플랫폼 개발을 위한 신기술의 도입은 세계의 디지털 병리학 시장의 성장을 이끌 것으로 예측됩니다. 예를 들어, 2022년 6월에는 소프트웨어 기업인 Tribun Health가 디지털 병리학 슬라이드 및 기타 멀티미디어 문서를 공유하는 데 활용되는 온라인 원격 병리 플랫폼 TeleSlide Patho 5를 발표했습니다.

시장 기업 간의 제휴 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2022년 9월 23일에는 디지털 병리학 솔루션 및 임상 AI 용도 제공업체인 Paige AI, Inc.와 전체 슬라이드 스캐너 제조업체인 OptraScan이 미국, 유럽 연합(EU) 국가, 영국에서 디지털 병리학 기술 채택을 효율화하기 위한 제휴를 발표했습니다. 양사의 목표는 유리 병리 슬라이드의 디지털화에서 장벽을 낮춰 종양학 및 병리학 워크플로를 개선하는 것입니다.

본 보고서의 주요 특징

• 본 보고서는 세계의 디지털 병리학 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측 기간(2025-2032년) 동안의 시장 규모 및 CAGR을 제공합니다.
• 또한 각 부문의 잠재적인 수익 기회를 밝히고 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 본 보고서에서는 촉진요인 및 억제요인과 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 세계의 디지털 병리학 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다양한 매개 변수를 기반으로 제시됩니다. 주요 분석 대상 기업은 Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Microscan Technologies, Inc., Koninklijke Philips NV, Sectra AB, Propath UK Limited, Inspirata, Inc., Hamatsu Biosciences, Aiforia, Xybion Digital Inc. 등이 있습니다.
• 본 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
• '세계의 디지털 병리학 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자는 세계의 디지털 병리학 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 실시할 수 있습니다.

목차

제1장 분석 목적 및 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 매력도 분석
  • 시장 기회
• 제품 발매
• 기업 합병 및 인수(M&A), 제휴
• 규제 가이드라인 및 컴플라이언스
• 주요 동향
• PEST 분석
• 기술 동향
• Porter's Five Forces 분석
• 가격 분석(2025년)

제4장 세계의 디지털 병리학 시장 : 제품 유형별(2020-2032년)

• 화상 해석 소프트웨어
• 스캐너
• 서비스

제5장 세계의 디지털 병리학 시장 : 치료 영역별(2020-2032년)

• 종양
• 혈액질환
• 자가면역질환
• 피부과
• 기타

제6장 세계의 디지털 병리학 시장 : 기술별(2020-2032년)

• 면역조직화학
• ISH 및 FISH
• 면역형광법
• 기타

제7장 세계의 디지털 병리학 시장 : 최종 사용자별(2020-2032년)

• 제약 및 생명공학 기업
• 진단실험실
• 병원 검사실
• 기타(연구기관, 전문센터 등)

제8장 세계의 디지털 병리학 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제9장 경쟁 구도

• Leica Biosystems Nussloch GmbH
• Olympus Corporation
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• GE Healthcare
• Mikroscan Technologies, Inc
• Koninklijke Philips NV
• Sectra AB
• Propath UK Limited
• Inspirata, Inc.
• Hamamatsu Photonics, Inc.
• OracleBio Limited
• MD Biosciences
• Aiforia
• Xybion Digital Inc.
• Nucleai, Inc

제10장 섹션

• 분석 방법
• Coherent Market Insights에 대해

영문목차

Digital Pathology Market is estimated to be valued at USD 1,112.8 Mn in 2025 and is expected to reach USD 2,491.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.2% from 2025 to 2032.

Digital pathology is the process of digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer, typically on a computer monitor or mobile device. Digital pathology offers a better viewing experience, which enhances analysis. This lowers diagnostic error rates. These tools additionally provide service providers immediate access to earlier cases for comparison. These advanced systems store data for use in long-term predictive analysis. Specimens are barcoded to reduce the chance of misidentification. Also, this removes concerns about lost data due to slide breakage. In the modern world, digital pathology has many benefits including improved disease diagnosis accuracy, quicker recovery times, increased pathologist productivity, and so on. As a result of these benefits, healthcare facilities are increasingly using digital pathology platforms for disease diagnosis, and major market players are getting involved in product launch process.

Market Dynamics

The use of new technologies for the development of innovative digital pathology platform is expected to drive the growth of the global digital pathology market over the forecast period. For instance, in June 2022, Tribun Health, a software company, launched TeleSlide Patho 5, an online telepathology platform which is utilized for sharing digital pathology slides and other multimedia documents.

Increasing number of partnerships by the market players is expected to drive the market growth over forecast period. For instance, on September 23, 2022, Paige AI, Inc., a provider of digital pathology solutions and clinical AI applications, and OptraScan, a producer of whole slide scanners, announced a partnership to streamline the adoption of digital pathology technology in the U.S., European Union countries, and U.K. The companies' goal is to lower obstacles to glass pathology slide digitization, which will improve oncology and pathology workflows.

Key features of the study

• This report will provide in-depth analysis of the Global Digital Pathology Market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It will elucidate potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global Digital Pathology Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Global Digital Pathology Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Digital Pathology Market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2025 - 2032)
  • Image Analysis Software
  • Scanner
  • Services
• Therapeutic Area Insights (Revenue, USD Mn, 2025 - 2032)
  • Oncology
  • Hematology
  • Autoimmune Disorders
  • Dermatology
  • Others
• Technology Type Insights (Revenue, USD Mn, 2025 - 2032)
  • Immunohistochemistry
  • ISH & FISH
  • Immunofluorescence
  • Others
• Industry Insights (Revenue, USD Mn, 2025 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Labs
  • Hospital Laboratories
  • Others
• Regional Insights (Revenue, USD Mn, 2025 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Leica Biosystems Nussloch GmbH
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • GE Healthcare
  • Mikroscan Technologies, Inc.
  • Koninklijke Philips N.V.
  • Sectra AB
  • Propath UK Limited
  • Inspirata, Inc.
  • Hamamatsu Photonics, Inc.
  • OracleBio Limited
  • MD Biosciences
  • Aiforia
  • Xybion Digital Inc.
  • Nucleai, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2025)

4. Global Digital Pathology Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Image Analysis Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Scanner
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Bright Field Scanner
    • Fluorescence Scanner
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Installation and Integration
    • Maintenance Services
    • Consulting Services

5. Global Digital Pathology Market, By Therapeutic Area, 2020 -2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Autoimmune Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Digital Pathology Market, By Technology, 2020 -2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Immunohistochemistry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• ISH & FISH
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Immunofluorescence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Digital Pathology Market, By End User, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diagnostic Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hospital Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Research Institutes, Specialty Centers, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Digital Pathology Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Leica Biosystems Nussloch GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Olympus Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mikroscan Technologies, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sectra AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Propath UK Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Inspirata, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hamamatsu Photonics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OracleBio Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• MD Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aiforia
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Xybion Digital Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nucleai, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us